Search results for "Prognostic model"

showing 10 items of 19 documents

Comparison of prognostic models in patients with advanced Hodgkin disease

2001

Several prognostic systems have been elaborated for patients with Hodgkin disease (HD) over the last 12 years, but early identification of a reasonably large group of both low and high risk, advanced stage patients remains unsatisfactory.Seven well known models were applied to 516 patients with advanced HD, with 315 patients used for the study sample and 201 patients used for the test sample. Individual performances as well as joint performances were analyzed univariately and multivariately in relation to overall survival, recurrence free survival, and time to treatment failure by means of a proportional hazards model.None of the models identified a group containing10% of patients from the …

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentPopulationSample (statistics)DiseaseHodgkin disease; prognosis; modeling; survival; time to treatment failureInternal medicinemedicineHumansIn patientChildeducationTime to treatment failurePrognostic modelsAgededucation.field_of_studyProportional hazards modelbusiness.industryLinear modelMiddle AgedModels TheoreticalPrognosisHodgkin DiseaseSurvival AnalysisSurgeryOncologyFemalebusinessCancer
researchProduct

A complication risk score to evaluate clinical severity of thalassaemia syndromes

2020

The thalassaemia syndromes (TS) show different phenotype severity. Developing a reliable, practical and global tool to determine disease severity and tailor treatment would be of great value. Overall, 7910 patients were analysed with the aim of constructing a complication risk score (CoRS) to evaluate the probability of developing one or more complications. Nine independent variables were included in the investigation as predictors. Logistic regression models were used for Group A [transfusion-dependent thalassaemia (TDT)], Group B [transfused non-TDT (NTDT)] and Group C (non-transfused NTDT). Statistically significant predictors included age (years), haemoglobin levels, hepatic transaminas…

AdultMalemedicine.medical_specialtyAdolescentcomplicationsthalassaemiacomplicationrisk scoreLogistic regressionSeverity of Illness IndexGroup AGroup BHemoglobinsYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansprognostic modelBlood TransfusionClinical severityHemoglobinFramingham Risk ScoreEjection fractionReceiver operating characteristicbusiness.industryHematologyMiddle AgedPrognosisChelation TherapyThalassemia ...ROC Curve030220 oncology & carcinogenesisThalassemiaFemalecomplications; prognostic model; risk score; thalassaemiaComplicationbusiness030215 immunologyBritish Journal of Haematology
researchProduct

A Statistical Study to Analyze the Impact of External Weather Change on Chronic Pulmonary Infection in South Norway with Machine Learning Algorithms

2021

In this paper, we analyzed the holistic impact of external weather on chronic pulmonary infection in the Agder region with traditional machine learning algorithms. Millions of people are diagnosed with Chronic Obstructive Pulmonary Disease (COPD). Our study is dedicated in the Agder region, the Southern part of Norway. Norway has four seasons – winter (December-February), late winter/spring (March-May), Summer (June-August), and Autumn (September-November) in a year with average annual temperature approx. 7.5 °C | 45.5 °F and an annual rainfall of 1260 mm or 49.6 in. in Kristiansand. As predicted by the World Health Organization (WHO), in 2016, Norway suffered from 8% mortality due to c(1)h…

COPDbusiness.industryLate winterPulmonary diseasePulmonary infectionLogistic regressionmedicine.diseaseMachine learningcomputer.software_genreWorld healthGeographyAir temperaturemedicineArtificial intelligencebusinessAlgorithmcomputerPrognostic models
researchProduct

Radiomics: A New Biomedical Workflow to Create a Predictive Model

2020

‘Radiomics’ is utilized to improve the prediction of patient overall survival and/or outcome. Target segmentation, feature extraction, feature selection, and classification model are the fundamental blocks of a radiomics workflow. Nevertheless, these blocks can be affected by several issues, i.e. high inter- and intra-observer variability. To overcome these issues obtaining reproducible results, we propose a novel radiomics workflow to identify a relevant prognostic model concerning a real clinical problem. In the specific, we propose an operator-independent segmentation system with the consequent automatic extraction of radiomics features, and a novel feature selection approach to create a…

Computer sciencebusiness.industryFeature extractionPattern recognitionFeature selectionWorkflowRadiomicsSegmentation systemFeature selection Magnetic Resonance (MR) Prostate Radiomics SegmentationPrognostic modelOverall survivalSegmentationArtificial intelligencebusiness
researchProduct

Standardisierte pathoanatomische Befunddokumentation auf den ADT-Tumorb�gen f�r Malignome des Mundes, der Kiefer und des Gesichts (Version III)

1995

The documentation form for pathohistologic findings (version III) for tumors of the maxillofacial region is presented. It is part of the site-specific documentation of the German Association of Tumor Centers (ADT). Its handling is explained by instructions which are based on the ICD-O classification and the TNM system. The prognostic relevance of the standardized documentation has already been proven by various histomorphologic investigations concerning oral and oropharyngeal cancer. By means of a multicentric observational study the German Austrian Swiss co-operative group DOSAK will develop a new prognostic model for oral and oropharyngeal cancer.

Lymphatic metastasismedicine.medical_specialtyPathologybusiness.industryGeneral surgeryMEDLINECancermedicine.diseaselanguage.human_languagePathology and Forensic MedicineGermanDocumentationlanguagePrognostic modelMedicineNeoplasm stagingObservational studybusinessDer Pathologe
researchProduct

Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma

2015

Background & aims To develop an individual prognostic calculator for patients with unresectable hepatocellular carcinoma (HCC) undergoing trans-arterial chemo-embolization (TACE). Methods Data from two prospective databases, regarding 361 patients who received TACE as first-line therapy (2000-2012), were reviewed in order to refine available prognostic tools and to develop a continuous individual web-based prognostic calculator. Patients with neoplastic portal vein invasion were excluded from the analysis. The model was built following a bootstrap resampling procedure aimed at identifying prognostic predictors and by carrying out a 10-fold cross-validation for accuracy assessment by means o…

MaleOncologymedicine.medical_specialtyCarcinoma HepatocellularSurvivalHepatocellular carcinomaPrognosimedicine.medical_treatmentPortal veinEmbolization03 medical and health sciences0302 clinical medicineText miningSerum total bilirubinInternal medicineBiomarkers TumorHumansMedicineProspective StudiesEmbolizationChemoembolization TherapeuticAgedHepatologyPortal Veinbusiness.industryLiver NeoplasmsBilirubinMiddle AgedPrognosismedicine.diseaseSurvival AnalysisSurgeryClinical PracticeItaly030220 oncology & carcinogenesisHepatocellular carcinomaMultivariate AnalysisCohortTrans-arterial chemo-embolizationPrognostic modelFemale030211 gastroenterology & hepatologybusinessLiver International
researchProduct

Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY …

2021

Objectives: We aimed to develop and validate a prediction model, based on clinical history and examination findings on initial diagnosis of coronavirus disease 2019 (COVID-19), to identify patients at risk of critical outcomes. Methods: We used data from the SEMI-COVID-19 Registry, a cohort of consecutive patients hospitalized for COVID-19 from 132 centres in Spain (23rd March to 21st May 2020). For the development cohort, tertiary referral hospitals were selected, while the validation cohort included smaller hospitals. The primary outcome was a composite of in-hospital death, mechanical ventilation, or admission to intensive care unit. Clinical signs and symptoms, demographics, and medical…

Microbiology (medical)medicine.medical_specialtyEvidence-based medicinePrognostic modelsReferralMedicinaCritical IllnessLogistic regressionInitial assessmentRisk Assessmentlaw.inventionlawmedicineHumansMedical historyGeneralizability theoryHospital MortalityRetrospective Studiesbusiness.industryMedicina basada en l'evidènciaCOVID-19Easily obtained clinical variablesGeneral MedicineModels Theoreticalmedicine.diseaseIntensive care unitConfidence intervalHospitalizationInfectious DiseasesSpainEmergency medicineCohortCritical illnessbusinessKidney disease
researchProduct

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis

2020

BACKGROUND AND OBJECTIVE MYELOFIBROSIS: is an infrequent chronic myeloproliferative neoplasm. We aimed to describe the clinico-biological characteristics, treatment, and evolutive course of myelofibrosis patients in Spain.; MATERIAL AND METHODS: A total of 1,000 patients from the Spanish Registry of Myelofibrosis diagnosed with primary (n=641) or secondary (n=359) myelofibrosis were analysed.; RESULTS: Median age was 68 years. The frequency of constitutional symptoms, moderate to severe anaemia (Hb<10g/dL), and symptomatic splenomegaly was 35%, 36%, and 17%, respectively. The rate of thrombosis and haemorrhage was 1.96 and 1.6 events per 100 patient-years, respectively. The cumulative incid…

Moderate to severePediatricsmedicine.medical_specialtyConstitutional symptomsbusiness.industrymedicine.diseaseTransplantation03 medical and health sciences0302 clinical medicineChronic Myeloproliferative NeoplasmClinical heterogeneitymedicineElderly people030212 general & internal medicineMyelofibrosisbusinessPrognostic modelsMedicina Clínica (English Edition)
researchProduct

A prospective trial for defining a subset of patients with limited metastatic gastric cancer who may be candidates for bimodal treatment strategies: …

2012

4090 Background: The utility of surgery for metastatic gastric cancer is debated. A prospective trial was performed to evaluate a prognostic model for selecting patients (pts) treated with systemic chemotherapy (ct) who may also be candidates for surgical intervention. Methods: Using a predefined algorithm pts with untreated gastric cancer were prospectively stratified into 3 groups: operable (OD), limited metastatic (LD), or extensive metastatic (ED) disease and treated with 5-FU, oxaliplatin, leucovorin and docetaxel (FLOT). LD was defined as: distant intra-abdominal lymph node metastases only or/and a maximum of 1 organ involved, normal serum alkaline phosphatase, &lt; 5 liver lesions, …

OncologyCancer Researchmedicine.medical_specialtyOncologyProspective trialbusiness.industryInternal medicinePrognostic modelMedicineTreatment strategybusinessMetastatic gastric cancerJournal of Clinical Oncology
researchProduct

Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study

2021

Background: Sorafenib is the gold standard therapy for the advanced hepatocellular carcinoma (HCC). No scoring/staging is universally accepted to predict the survival of these patients. Aims: To evaluate the accuracy of the available prognostic models for HCC to predict the survival of advanced HCC patients treated with Sorafenib included in the Italian Liver Cancer (ITA.LI.CA.) multicenter cohort. Methods: The performance of several prognostic scores was assessed through a Cox regression-model evaluating the C-index and the Akaike Information Criterion (AIC). Results: Data of 1129 patients were analyzed. The mean age of patients was 61.6 years, and 80.8% were male. During a median follow-u…

OncologyMaleSurvivalHepatocellular carcinomaCohort study Hepatocellular carcinoma Prognosis Sorafenib SurvivalSeverity of Illness IndexAntineoplastic Agent0302 clinical medicineProspective StudiesLiver NeoplasmsGastroenterologyMiddle AgedSorafenibPrognosisTreatment OutcomeItalyLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaCohort030211 gastroenterology & hepatologyFemaleLiver cancerCohort studymedicine.drugCohort studySorafenibCohort study; Hepatocellular carcinoma; Prognosis; Sorafenib; Survivalmedicine.medical_specialtyCarcinoma HepatocellularPrognosiSettore MED/12 - GASTROENTEROLOGIAAntineoplastic AgentsRisk Assessment03 medical and health sciencesInternal medicinemedicineHumansneoplasmsPrognostic modelsNeoplasm StagingProportional Hazards ModelsRetrospective StudiesHepatologybusiness.industrySettore MED/09 - MEDICINA INTERNAGold standardmedicine.diseasedigestive system diseasesMulticenter studybusiness
researchProduct